GRHL2 and neoplasm: Taken together, these data suggest that specific CREs were reprogrammed by the master regulator’s shift from ER to GRHL2 within a single luminal tumor, which led to the establishment of tumor subpopulations with potential for intrinsic endocrine resistance and ultimately poor outcomes.